BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND SRSF2, Q01130, 6427, SFRS2 AND Diagnosis
32 results:

  • 1. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
    Cargo C; Bernard E; Beinortas T; Bolton KL; Glover P; Warren H; Payne D; Ali R; Khan A; Short M; Van Hoppe S; Smith A; Taylor J; Evans P; Papaemmanuil E; Crouch S
    Lancet Haematol; 2024 Jan; 11(1):e51-e61. PubMed ID: 38135373
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. diagnosis- and Prognosis-Related Gene Alterations in
    Morishita S; Komatsu N
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
    [No Abstract]    [Full Text] [Related]  

  • 3. Co-occurring mutations in ASXL1, srsf2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.
    Jain T; Ware AD; Dalton WB; Pasca S; Tsai HL; Gocke CD; Gondek LP; Xian RR; Borowitz MJ; Levis MJ
    Leuk Res; 2023 Aug; 131():107345. PubMed ID: 37354804
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.
    Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Lewandowski K
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4789-4803. PubMed ID: 36242602
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.
    Kennedy VE; Perkins C; Reiter A; Jawhar M; Lübke J; Kluin-Nelemans HC; Shomali W; Langford C; Abuel J; Hermine O; Niedoszytko M; Gorska A; Mital A; Bonadonna P; Zanotti R; Tanasi I; Mattsson M; Hagglund H; Triggiani M; Yavuz AS; Panse J; Christen D; Heizmann M; Shoumariyeh K; Müller S; Elena C; Malcovati L; Fiorelli N; Wortmann F; Vucinic V; Brockow K; Fokoloros C; Papageorgiou SG; Breynaert C; Bullens D; Doubek M; Ilerhaus A; Angelova-Fischer I; Solomianyi O; Várkonyi J; Sabato V; Rüfer A; Schug TD; Hermans MAW; Fortina AB; Caroppo F; Bumbea H; Gulen T; Hartmann K; Elberink HO; Schwaab J; Arock M; Valent P; Sperr WR; Gotlib J
    Blood Adv; 2023 May; 7(9):1713-1724. PubMed ID: 36094848
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2022 Mar; 97(3):352-372. PubMed ID: 34985762
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Systemic Mastocytosis: Advances in diagnosis and Current Management.
    Pullarkat ST; Wu W; Pullarkat V
    Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.
    Koerber RM; Held SAE; Vonnahme M; Feldmann G; Wenzel J; Gütgemann I; Brossart P; Heine A
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):743-748. PubMed ID: 34529129
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical and Molecular Approach to Adult-Onset, Neoplastic Monocytosis.
    Shallis RM; Siddon AJ; Zeidan AM
    Curr Hematol Malig Rep; 2021 Jun; 16(3):276-285. PubMed ID: 33890194
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [CT spectral curve in differentiating spinal tumor metastasis and infections].
    Yuan Y; Lang N; Yuan HS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(1):183-187. PubMed ID: 33550354
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
    Pardanani A
    Am J Hematol; 2021 Apr; 96(4):508-525. PubMed ID: 33524167
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Importance of Adequate Diagnostic Workup for Correct diagnosis of Advanced Systemic Mastocytosis.
    Schwaab J; Cabral do O Hartmann N; Naumann N; Jawhar M; Weiß C; Metzgeroth G; Schmid A; Lübke J; Reiter L; Fabarius A; Cross NCP; Sotlar K; Valent P; Kluin-Nelemans HC; Hofmann WK; Horny HP; Panse J; Reiter A
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3121-3127.e1. PubMed ID: 32422371
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2020 Jan; 95(1):97-115. PubMed ID: 31736132
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia.
    Hwang SM; Kim SM; Nam Y; Kim J; Kim S; Ahn YO; Park Y; Yoon SS; Shin S; Kwon S; Lee DS
    Leuk Res; 2019 Sep; 84():106190. PubMed ID: 31377458
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies.
    Duarte BKL; Yamaguti-Hayakawa GG; Medina SS; Siqueira LH; Snetsinger B; Costa FF; Rauh MJ; Ozelo MC
    Br J Haematol; 2019 Sep; 186(5):724-734. PubMed ID: 31124578
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.
    Edahiro Y; Araki M; Inano T; Ito M; Morishita S; Misawa K; Fukuda Y; Imai M; Ohsaka A; Komatsu N
    Eur J Haematol; 2019 Jun; 102(6):516-520. PubMed ID: 30977935
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada.
    Arora N; Talhouk A; McAlpine JN; Law MR; Hanley GE
    Int J Gynecol Cancer; 2019 Mar; 29(3):593-598. PubMed ID: 30821698
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.
    Pardanani A
    Am J Hematol; 2019 Mar; 94(3):363-377. PubMed ID: 30536695
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis.
    Hu Z; Ramos CEB; Medeiros LJ; Zhao C; Yin CC; Li S; Hu S; Wang W; Thakral B; Xu J; Verstovsek S; Lin P
    Hum Pathol; 2019 Mar; 85():290-298. PubMed ID: 30447300
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes.
    Shingai N; Harada Y; Iizuka H; Ogata Y; Doki N; Ohashi K; Hagihara M; Komatsu N; Harada H
    Int J Hematol; 2018 Dec; 108(6):598-606. PubMed ID: 30353274
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.